News
MSD Australia & New Zealand is astonished that after eight years of dialogue and consideration, the Pharmaceutical Benefits Advisory Committee (PBAC ...
Luke FaulksLocal Journalism Initiative ReporterPique NewsmagazineA Pemberton resident and her family are appealing to the ...
12h
TipRanks on MSNBristol-Myers Squibb’s New Lung Cancer Study: Potential Market Impact
Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...
13h
TipRanks on MSNIncyte’s Phase 3 Study on Pembrolizumab and Epacadostat: Key Insights for Investors
Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Incyte Corporation recently completed a Phase 3 clinical ...
"Prior to the EV-302 clinical trial, the treatment of advanced bladder cancer treatment hadn't significantly changed since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results